… demonstrated remarkable performance in lung cancer cell lines with high … with the anticancer drug, doxorubicin (DOX), and conjugated them … tumor suppression, reducing the lung tumor burden to just 4%, … activity in a human lung cancer organoid (LCO) xenograft …

… clinical management of lung cancer by investigating various … to therapeutic interventions in lung cancer.20,21 Consequently, … (b) amentoflavone, (c) doxorubicin, (d) JSH-23, and … treatment of cancers, including lung cancer. Currently, available therapeutic …

… cells from the initial lung tumor, their migration into … Brain Metastasis in Lung Cancer. Primary lung cancer cells move from … In contrast to original lung tumors, which might manifest … formulations is liposome-encapsulated doxorubicin (Doxil), which is …

… of metastatic melanoma lung tumors in vivo with … al. Targeted delivery of doxorubicin by nano-loaded mesenchymal … study protocol among advanced lung cancer patients. Front Public Health … accumulation in small metastatic lung tumors. J Nanobiotechnology. 2020 …

… ) and non-small cell lung cancer (NSCLC). In patients with … test. Non-Small Cell Lung Cancer KEYTRUDA, in combination with … nonsquamous non-small cell lung cancer (NSCLC), with no … and paclitaxel followed by doxorubicin or epirubicin and cyclophosphamide) …

… has surpassed lung cancer in incidence, lung cancer remains the … -stage lung cancer.65 In 2002, Japanese lung cancer treatment … stage central lung cancer.68 However, most lung cancer cases … 2 cell membranes, encapsulating doxorubicin (DOX), showed prolonged …

… cardiotoxicity commonly associated with doxorubicin, a widely used … of cardiotoxicity related to doxorubicin therapy.” This trial … as breast, ovarian and lung cancer, among others. Global … its promising combination with doxorubicin could potentially provide …

… metastases. Chemotherapeutics such as doxorubicin (Dox), epirubicin, paclitaxel … breast cancer,3 lung cancer,4 sarcomas,5 …  human lung cancer cells, and H226 murine lung cancer cells … Characterization of ELP–Doxorubicin Conjugates and Characterization …

… patients with non-small cell lung cancer (NSCLC), treatment with the Janus … month at the 2025 European Lung Cancer Congress (ELCC) in Paris. As … works with or without cyclophosphamide, doxorubicin, vincristine and prednisone (CHOP) in …

… amount of attention in treating lung cancer. However, a full understanding … CCAT1 on the lung cancer cell proliferation, apoptosis, and doxorubicin (DOX) sensitivity, … CCAT1 decreased the sensitivity to doxorubicin in lung cancer cells by regulating the …